NOTE 9 - STOCKHOLDERS' EQUITY (Details) - USD ($)						3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 01, 2019	May 07, 2018	Aug. 07, 2017	Apr. 21, 2017	Sep. 16, 2016	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Nov. 02, 2015	Aug. 04, 2014	Apr. 01, 2013
NOTE 9 - STOCKHOLDERS' EQUITY (Details) [Line Items]
Gain (Loss) on Extinguishment of Debt (in Dollars)						$ 33,203	$ 80,200	$ 21,892	$ 45,013
Stock Issued During Period, Shares, Issued for Services								3,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value (in Dollars)						33,252		$ 33,252
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value (in Dollars)						$ 13,685		$ 13,685
Share Price (in Dollars per share)						$ 0.006		$ 0.006
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures	33,400,000
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price (in Dollars per share)	$ 0.00557
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	4 years
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Fair Value of Options (in Dollars)	$ 192,189
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	215.10%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	1.45%
Share-based Payment Arrangement, Noncash Expense (in Dollars)								$ 586,382	$ 812,300
Aggregate Intrinsic Value of the Issued and Exercisable Warrants (in Dollars)								0.006
Share-based Payment Arrangement, Option [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Payment Arrangement, Noncash Expense (in Dollars)						$ 174,450		512,882
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount (in Dollars)						$ 1,594,448		$ 1,594,448
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition								1 year 113 days
Accounts Payable [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (Details) [Line Items]
Stock Issued During Period, Shares, Other								16,166,984
Gain (Loss) on Extinguishment of Debt (in Dollars)										$ (21,892)
Bioheart 2013 Omnibus Equity Compensation Plan [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized											500,000,000	100,000	50,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized		100,000,000	30,000,000	25,000,000	25,000,000